Recap: Arrowhead Pharma Q4 Earnings

Arrowhead Pharmaceuticals, Inc. -0.92%

Arrowhead Pharmaceuticals, Inc.




Arrowhead Pharma (NASDAQ:ARWR) reported its Q4 earnings results on Wednesday, November 29, 2023 at 04:01 PM.

Here's what investors need to know about the announcement.


Arrowhead Pharma missed estimated earnings by 70.0%, reporting an EPS of $-1.02 versus an estimate of $-0.6.

Revenue was down $15.48 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.38 which was followed by a 10.78% drop in the share price the next day.

Here's a look at Arrowhead Pharma's past performance:

Quarter Q3 2023 Q2 2023 Q1 2023 Q4 2022
EPS Estimate -0.58 -0.64 0.44 -0.16
EPS Actual -0.96 0.45 -0.39 -0.81
Revenue Estimate 48.19M 45.48M 162.52M 50.44M
Revenue Actual 15.82M 146.27M 62.55M 31.57M

To track all earnings releases for Arrowhead Pharma visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Every question you ask will be answered
Scan the QR code to contact us
Also you can contact us via